Catheter-related complications
| Complication . | Episodes (n) . | Time to Complication (days)3-150 . |
|---|---|---|
| Bacteremic infection | ||
| Coagulase-negative staphylococci | 3 | 452, 911, 1474 |
| S aureus | 3 | 59, (571, 639) |
| MRSA | 2 | (376, 443) |
| E coli | 1 | 112 |
| Achromobacter spp | 1 | 127 |
| Port or exit-site infection | ||
| Coagulase-negative staphylococci | 8 | 320, (520, 576, 688), 995, 1241, 1349, 1641 |
| S aureus | 1 | 92 |
| MRSA | 1 | 907 |
| Other3-151 | 1 | 68 |
| Thromboembolism | ||
| Line thrombosis | 4 | 70, 410, 513, 1659 |
| Pulmonary embolism | 2 | 578 |
| Left internal jugular thrombosis | 1 | 84 |
| Superior vena cava thrombosis | 1 | 410, 1659 |
| Mechanical | ||
| Occlusion | 2 | 536, 1851 |
| Perforation of superior vena cava | 1 | 578 |
| Disconnection and migration | 1 | 43 |
| Complication . | Episodes (n) . | Time to Complication (days)3-150 . |
|---|---|---|
| Bacteremic infection | ||
| Coagulase-negative staphylococci | 3 | 452, 911, 1474 |
| S aureus | 3 | 59, (571, 639) |
| MRSA | 2 | (376, 443) |
| E coli | 1 | 112 |
| Achromobacter spp | 1 | 127 |
| Port or exit-site infection | ||
| Coagulase-negative staphylococci | 8 | 320, (520, 576, 688), 995, 1241, 1349, 1641 |
| S aureus | 1 | 92 |
| MRSA | 1 | 907 |
| Other3-151 | 1 | 68 |
| Thromboembolism | ||
| Line thrombosis | 4 | 70, 410, 513, 1659 |
| Pulmonary embolism | 2 | 578 |
| Left internal jugular thrombosis | 1 | 84 |
| Superior vena cava thrombosis | 1 | 410, 1659 |
| Mechanical | ||
| Occlusion | 2 | 536, 1851 |
| Perforation of superior vena cava | 1 | 578 |
| Disconnection and migration | 1 | 43 |